Using biomarkers in clinical practice in airway disease: asthma and COPD
Aims : To review the role of biomarkers in airways disease (COPD and asthma)- notably induced sputum, blood eosinophils, exhaled nitric oxide and airway hyper-responsiveness; to consider the biomarkers in relation to risk stratification and identification of treatment responders; to reflect on the biomarkers in the identification of a clinical phenotype, the monitoring of disease, and in new drug development.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Paediatrician, Respiratory critical care physician, Journalist
Epidemiology, General respiratory patient care, Pulmonary function testing